295 related articles for article (PubMed ID: 25468386)
1. The future burden of CKD in the United States: a simulation model for the CDC CKD Initiative.
Hoerger TJ; Simpson SA; Yarnoff BO; Pavkov ME; Ríos Burrows N; Saydah SH; Williams DE; Zhuo X
Am J Kidney Dis; 2015 Mar; 65(3):403-11. PubMed ID: 25468386
[TBL] [Abstract][Full Text] [Related]
2. Modeling the impact of obesity on the lifetime risk of chronic kidney disease in the United States using updated estimates of GFR progression from the CRIC study.
Yarnoff BO; Hoerger TJ; Shrestha SS; Simpson SK; Burrows NR; Anderson AH; Xie D; Chen HY; Pavkov ME;
PLoS One; 2018; 13(10):e0205530. PubMed ID: 30339684
[TBL] [Abstract][Full Text] [Related]
3. Lifetime incidence of CKD stages 3-5 in the United States.
Grams ME; Chow EK; Segev DL; Coresh J
Am J Kidney Dis; 2013 Aug; 62(2):245-52. PubMed ID: 23566637
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of Pneumococcal Vaccination Among Patients With CKD in the United States.
Ishigami J; Padula WV; Grams ME; Chang AR; Jaar B; Gansevoort RT; Bridges JFP; Kovesdy CP; Uchida S; Coresh J; Matsushita K
Am J Kidney Dis; 2019 Jul; 74(1):23-35. PubMed ID: 30898360
[TBL] [Abstract][Full Text] [Related]
5. CKD Awareness Among US Adults by Future Risk of Kidney Failure.
Chu CD; McCulloch CE; Banerjee T; Pavkov ME; Burrows NR; Gillespie BW; Saran R; Shlipak MG; Powe NR; Tuot DS;
Am J Kidney Dis; 2020 Aug; 76(2):174-183. PubMed ID: 32305206
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of cardiovascular disease burden and therapeutic goal attainment in US adults with chronic kidney disease: an analysis of national health and nutritional examination survey data, 2001-2010.
Kuznik A; Mardekian J; Tarasenko L
BMC Nephrol; 2013 Jun; 14():132. PubMed ID: 23802885
[TBL] [Abstract][Full Text] [Related]
7. The myth of the future burden of CKD in United States.
Delanaye P; El Nahas M; Glassock RJ
Am J Kidney Dis; 2015 Jul; 66(1):171-2. PubMed ID: 26111905
[No Abstract] [Full Text] [Related]
8. In reply to 'the myth of the future burden of CKD in United States'.
Hoerger TJ; Ríos Burrows N; Pavkov ME
Am J Kidney Dis; 2015 Jul; 66(1):172. PubMed ID: 26111907
[No Abstract] [Full Text] [Related]
9. Trends in Prevalence of Chronic Kidney Disease in the United States.
Murphy D; McCulloch CE; Lin F; Banerjee T; Bragg-Gresham JL; Eberhardt MS; Morgenstern H; Pavkov ME; Saran R; Powe NR; Hsu CY;
Ann Intern Med; 2016 Oct; 165(7):473-481. PubMed ID: 27479614
[TBL] [Abstract][Full Text] [Related]
10. State-Level Awareness of Chronic Kidney Disease in the U.S.
Dharmarajan SH; Bragg-Gresham JL; Morgenstern H; Gillespie BW; Li Y; Powe NR; Tuot DS; Banerjee T; Burrows NR; Rolka DB; Saydah SH; Saran R;
Am J Prev Med; 2017 Sep; 53(3):300-307. PubMed ID: 28410862
[TBL] [Abstract][Full Text] [Related]
11. Chronic kidney disease, health-related quality of life and their associated economic burden among a nationally representative sample of community dwelling adults in England.
Nguyen NTQ; Cockwell P; Maxwell AP; Griffin M; O'Brien T; O'Neill C
PLoS One; 2018; 13(11):e0207960. PubMed ID: 30475893
[TBL] [Abstract][Full Text] [Related]
12. Characteristics of uninsured Americans with chronic kidney disease.
Hall YN; Rodriguez RA; Boyko EJ; Chertow GM; O'Hare AM
J Gen Intern Med; 2009 Aug; 24(8):917-22. PubMed ID: 19506974
[TBL] [Abstract][Full Text] [Related]
13. Annual health care resource utilization and cost among type 2 diabetes patients with newly recognized chronic kidney disease within a large U.S. administrative claims database.
Folkerts K; Petruski-Ivleva N; Kelly A; Fried L; Blankenburg M; Gay A; Kovesdy CP
J Manag Care Spec Pharm; 2020 Dec; 26(12):1506-1516. PubMed ID: 33251992
[No Abstract] [Full Text] [Related]
14. Visual Impairment and Major Eye Diseases in Chronic Kidney Disease: The National Health and Nutrition Examination Survey, 2005-2008.
Zhu Z; Liao H; Wang W; Scheetz J; Zhang J; He M
Am J Ophthalmol; 2020 May; 213():24-33. PubMed ID: 31945332
[TBL] [Abstract][Full Text] [Related]
15. Cardiovascular risk factor burden, treatment, and control among adults with chronic kidney disease in the United States.
Foster MC; Rawlings AM; Marrett E; Neff D; Willis K; Inker LA; Coresh J; Selvin E
Am Heart J; 2013 Jul; 166(1):150-6. PubMed ID: 23816034
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of chronic kidney disease in the United States.
Coresh J; Selvin E; Stevens LA; Manzi J; Kusek JW; Eggers P; Van Lente F; Levey AS
JAMA; 2007 Nov; 298(17):2038-47. PubMed ID: 17986697
[TBL] [Abstract][Full Text] [Related]
17. Chronic kidney disease in US adults with type 2 diabetes: an updated national estimate of prevalence based on Kidney Disease: Improving Global Outcomes (KDIGO) staging.
Bailey RA; Wang Y; Zhu V; Rupnow MF
BMC Res Notes; 2014 Jul; 7():415. PubMed ID: 24990184
[TBL] [Abstract][Full Text] [Related]
18. The cost-effectiveness of using chronic kidney disease risk scores to screen for early-stage chronic kidney disease.
Yarnoff BO; Hoerger TJ; Simpson SK; Leib A; Burrows NR; Shrestha SS; Pavkov ME;
BMC Nephrol; 2017 Mar; 18(1):85. PubMed ID: 28288579
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of anemia in chronic kidney disease in the United States.
Stauffer ME; Fan T
PLoS One; 2014; 9(1):e84943. PubMed ID: 24392162
[TBL] [Abstract][Full Text] [Related]
20. Estimating prevalence of CKD stages 3-5 using health system data.
Shahinian VB; Hedgeman E; Gillespie BW; Young EW; Robinson B; Hsu CY; Plantinga LC; Burrows NR; Eggers P; Saydah S; Powe NR; Saran R;
Am J Kidney Dis; 2013 Jun; 61(6):930-8. PubMed ID: 23489675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
